𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Doxazosin in patients with hypertension

✍ Scribed by K. A. Conrad; T. C. Fagan; M. J. Mackie; P. V. Mayshar; S. Lee; J. F. Souhrada; F. C. Falkner; J. D. Lazar


Publisher
Springer
Year
1988
Tongue
English
Weight
423 KB
Volume
35
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Effects of doxazosin and atenolol on the
✍ J. -H. Jansson; B. Johansson; K. Boman; T. K. Nilsson πŸ“‚ Article πŸ“… 1991 πŸ› Springer 🌐 English βš– 740 KB

Disturbances in the fibrinolytic system have been associated with cardiovascular disease and its risk factors. In the present study the effects of an alpha 1-adrenoceptor inhibitor (doxazosin) and a selective beta-adrenoceptor blocker (atenolol) on the fibrinolytic system have been evaluated. Eighty

Doxazosin in combination with atenolol i
✍ M. Searle; R. Dathan; S. Dean; C. C. Christensen; A. Westheim πŸ“‚ Article πŸ“… 1990 πŸ› Springer 🌐 English βš– 184 KB

Doxazosin (mean dose 11 mg) given once daily in combination with 100 mg atenolol (n = 44) was compared with placebo and atenolol (n = 43) in a double-blind, multicenter study in patients with mild to moderate essential hypertension. In the atenolol/doxazosin-treated group, standing blood pressure si